Denmark’s Corporate Giants Face Crossroads as Growth Momentum Slows
For years, Novo Nordisk and Ørsted stood as Denmark’s crown jewels, turning the small Nordic country into a global economic powerhouse. Novo’s meteoric rise on the back of its blockbuster obesity and diabetes drugs, and Ørsted’s
